We deliver structured market intelligence based on earnings analysis and institutional trading patterns.
As of April 16, 2026, The Oncology Institute Inc. (TOI) is trading at $3.54, posting an intraday gain of 3.21% during regular market hours. This analysis examines key technical price levels for TOI, recent market context for the specialty oncology care sector, and potential short-term price scenarios that market participants may monitor. No recently released quarterly earnings data is available for TOI at the time of writing, so current price action is largely being driven by technical flows and
The (TOI) Stock: Valuation Metrics (+3.21%) 2026-04-16 - Wyckoff Upthrust
TOI - Stock Analysis
3849 Comments
1915 Likes
1
Avanell
Influential Reader
2 hours ago
This triggered my “act like you know” instinct.
👍 220
Reply
2
Alecsandra
Power User
5 hours ago
Truly a master at work.
👍 155
Reply
3
Armanni
Active Contributor
1 day ago
This deserves attention, I just don’t know why.
👍 123
Reply
4
Breyell
Active Contributor
1 day ago
Expert US stock analyst coverage consensus and rating distribution analysis to understand market sentiment and Wall Street expectations for specific stocks. We aggregate analyst opinions to provide a consensus view of Wall Street expectations including price targets and ratings. We provide consensus ratings, price target analysis, and analyst sentiment for comprehensive coverage. Understand market expectations with our comprehensive analyst coverage and consensus analysis tools for sentiment investing.
👍 40
Reply
5
Manahil
Engaged Reader
2 days ago
Highlights trends in a logical and accessible manner.
👍 58
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.